missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Chemicals
  4. Organic compounds
  5. Unclassified Organic Compounds
  6. ARS-1630, MedChemExpress

ARS-1630, MedChemExpress

Product Code. p-200098627
Encompass_Preferred
Change view
Click to view available options
Quantity:
5 mg
10 mg
25 mg
50 mg
100 mg
Unit Size:
100mg
10mg
25mg
50mg
5mg
5 product options available for selection
Product selection table with 5 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
16475437 50 mg 50mg
16444086 25 mg 25mg
16432628 5 mg 5mg
16429306 100 mg 100mg
16420429 10 mg 10mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 5 options available.
5 options
This item is not returnable. View return policy
Product Code. 16475437 Supplier Medchem Express Supplier No. HYU00417

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

MedChemExpress ARS-1630, a less active enantiomer of ARS-1620, is a novel inhibitor of mutant K-ras G12C extracted from patent WO 2015054572 A1.

ARS-1630, a less active enantiomer of ARS-1620, is a novel inhibitor of mutant K-ras G12C extracted from patent WO 2015054572 A1.

Specifications

Chemical Name or Material ARS-1630
CAS 1698055-86-5
Color Yellow
Purity Grade Notes Research
Molecular Formula C21H17ClF2N4O2
Quantity 50 mg
Solubility Information DMSO : ≥ 100 mg/mL (232.10 mM)
SMILES C=CC(N1CCN(C2=C3C=C(Cl)[C@@]([C@@]4=C(O)C=CC=C4F)=C(F)C3=NC=N2)CC1)=O.[R]
Molecular Weight (g/mol) 430.84
Formula Weight 430.84
Percent Purity 97.25%
Grade Research
Physical Form Solid
For Use With (Application) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.